News dynamics
It is estimated that the market size of the domestic stem cell industry will reach 100 billion yuan by 2016.

It is estimated that the market size of the domestic stem cell industry will reach 100 billion yuan by 2016.

Medical Network, August 26-the State Health and Family Planning Commission and the State Food and Drug Administration recently jointly issued China's first "measures for the Administration of Stem Cell Clinical Research", which standardizes the institutional qualifications and conditions of stem cell clinical research. and explicitly prohibit the publication of stem cell clinical research advertisements, limit a number of measures to protect the rights and interests of patients. Data show that it is estimated that by 2016, the market size of the domestic stem cell industry will reach 100 billion yuan. Some people in the industry believe that with the announcement of the management measures, the stem cell industry, especially in the field of treatment, will usher in spring.

2019-09-27

View Details
Food and Drug Administration Launches 2015 National Safe Drug Use Month

Food and Drug Administration Launches 2015 National Safe Drug Use Month

According to the requirements of the "National Food and Drug Safety Science Popularization Action Plan (2011-2015)", the "National Safe Drug Month" (hereinafter referred to as the "Safety Month") is held every September. In order to effectively carry out this year's safety month activities, relevant matters are hereby notified as follows:

2019-09-27

View Details
The cost of using genetically modified yeast to make painkillers in the United States is expected to be reduced by 10 times.

The cost of using genetically modified yeast to make painkillers in the United States is expected to be reduced by 10 times.

Yeast can be used not only to make steamed bread, but also to make painkillers. Recently, a study published in "Science" introduced a method of using genetically modified yeast to produce morphine-based painkillers. The researchers said that the method can not only shorten the production cycle of drugs from a year to a few days, but also reduce the cost to one tenth of the traditional method. When the technology matures in the future, it is expected to greatly reduce the retail price of related drugs.

2015-08-26

View Details
Pharmaceutical August 2015 report: focus on the reform of state-owned enterprises in the pharmaceutical industry

Pharmaceutical August 2015 report: focus on the reform of state-owned enterprises in the pharmaceutical industry

The market plunged sharply in July, with all sectors falling sharply. Among them, the relatively small decline is the agriculture, forestry, animal husbandry and fishing, defense and military industry sector, followed by banking, leisure services and mining sector. In July, small-cap stocks fell more, while large-cap stocks fell relatively small. Although the pharmaceutical industry has a certain increase, but in view of China is about to enter an aging society, coupled with the performance support of pharmaceutical stocks, investors are still optimistic about pharmaceutical stocks, so the decline of pharmaceutical stocks is not large. And the pharmaceutical industry may have a good follow-up, investors can still be optimistic about the pharmaceutical industry.

2015-08-26

View Details
Global pharmaceutical sales will reach $1.3 trillion in 2018

Global pharmaceutical sales will reach $1.3 trillion in 2018

Thomson Reuters annual CMRFactbook pointed out that 46 new molecular entities were approved for listing in developed countries in 2014, which is far higher than the number in any year since 2005. At the same time, 2014 was also a year of outstanding sales, with $1 trillion. The sales of the United States challenged those who had a negative attitude towards the pharmaceutical industry.

2015-08-26

View Details
New drug development in China: How close are we to the first original drug?

New drug development in China: How close are we to the first original drug?

According to a data provided by the Tufts Center for Drug Development Research, the average cost of developing a new drug is about $2.6 billion. In 2013, the R & D investment of the world's top ten pharmaceutical companies accounted for 17.8 percent of sales, up to $60.39 billion, while the R & D investment of the top ten domestic pharmaceutical companies was only 1% of sales, about $0.3 billion.

2015-08-26

View Details
Antidepressant modafinil, or become the first

Antidepressant modafinil, or become the first "smart drug"

Modafinil (Modafinil), as an antidepressant drug for the treatment of sleep disorders such as narcolepsy, was approved by the US Food and Drug Administration (FDA) in 1998. Modafinil became the first marketed drug for the treatment of sleep disorders with good central excitatory effects and fewer side effects. Past studies have found that people who are sleep-deprived take modafinil and their mental state is significantly enhanced. But for normal people, modafinil this effect is not obvious. And modafinil can be used as an auxiliary drug for the treatment of depression to enhance the therapeutic effect. It is precisely because modafinil has

2015-08-26

View Details
< 1 >